# Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy

> **NCT07440901** · — · NOT_YET_RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Muscle-invasive Bladder Cancer

## Interventions

- **DRUG:** Immunotherapy plus chemotherapy

## Key facts

- **NCT ID:** NCT07440901
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2026-05-15
- **Final completion:** 2027-05-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07440901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07440901, "Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07440901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*